Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration

Cited 13 time in webofscience Cited 0 time in scopus
  • Hit : 245
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorChang, Jee Sukko
dc.contributor.authorKim, Kyung Hwanko
dc.contributor.authorKeum, Ki Changko
dc.contributor.authorNoh, Sung Hoonko
dc.contributor.authorLim, Joon Seokko
dc.contributor.authorKim, Hyo Songko
dc.contributor.authorRha, Sun Youngko
dc.contributor.authorLee, Yong Chanko
dc.contributor.authorHyung, Woo Jinko
dc.contributor.authorKoom, Woong Subko
dc.date.accessioned2016-12-01T08:01:30Z-
dc.date.available2016-12-01T08:01:30Z-
dc.date.created2016-11-28-
dc.date.created2016-11-28-
dc.date.issued2016-12-
dc.identifier.citationJOURNAL OF SURGICAL ONCOLOGY, v.114, no.7, pp.859 - 864-
dc.identifier.issn0022-4790-
dc.identifier.urihttp://hdl.handle.net/10203/214606-
dc.description.abstractBackground and ObjectivesTo classify patients with nonmetastatic advanced gastric cancer who underwent D2-gastrectomy into prognostic groups based on peritoneal and systemic recurrence risks. MethodsBetween 2004 and 2007, 1,090 patients with T3-4 or N+ gastric cancer were identified from our registry. Recurrence rates were estimated using a competing-risk analysis. Different prognostic groups were defined using recursive partitioning analysis (RPA). ResultsMedian follow-up was 7 years. In the RPA-model for peritoneal recurrence risk, the initial node was split by T stage, indicating that differences between patients with T1-3 and T4 cancer were the greatest. The 5-year peritoneal recurrence rates for patients with T4 (n=627) and T1-3 (n=463) disease were 34.3% and 9.1%, respectively. N stage and neural invasion had an additive impact on high-risk patients. The RPA model for systemic relapse incorporated N stage alone and gave two terminal nodes: N0-2 (n=721) and N3 (n=369). The 5-year cumulative incidences were 7.7% and 24.5%, respectively. ConclusionsWe proposed risk stratification models of peritoneal and systemic recurrence in patients undergoing D2-gastrectomy. This classification could be used for stratification protocols in future studies evaluating adjuvant therapies such as preoperative chemoradiotherapy. J. Surg. Oncol. 2016;114:859-864. (c) 2016 2016 Wiley Periodicals, Inc-
dc.languageEnglish-
dc.publisherWILEY-BLACKWELL-
dc.subjectRANDOMIZED CONTROLLED-TRIAL-
dc.subjectINTRAPERITONEAL CHEMOTHERAPY-
dc.subjectADJUVANT CHEMOTHERAPY-
dc.subjectCURATIVE SURGERY-
dc.subjectCOMPETING RISK-
dc.subjectPHASE-II-
dc.subjectS-1-
dc.subjectCHEMORADIOTHERAPY-
dc.subjectCARCINOMATOSIS-
dc.subjectCELLS-
dc.titleRecursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration-
dc.typeArticle-
dc.identifier.wosid000387028900014-
dc.identifier.scopusid2-s2.0-84992467397-
dc.type.rimsART-
dc.citation.volume114-
dc.citation.issue7-
dc.citation.beginningpage859-
dc.citation.endingpage864-
dc.citation.publicationnameJOURNAL OF SURGICAL ONCOLOGY-
dc.identifier.doi10.1002/jso.24405-
dc.contributor.nonIdAuthorChang, Jee Suk-
dc.contributor.nonIdAuthorKeum, Ki Chang-
dc.contributor.nonIdAuthorNoh, Sung Hoon-
dc.contributor.nonIdAuthorLim, Joon Seok-
dc.contributor.nonIdAuthorKim, Hyo Song-
dc.contributor.nonIdAuthorRha, Sun Young-
dc.contributor.nonIdAuthorLee, Yong Chan-
dc.contributor.nonIdAuthorHyung, Woo Jin-
dc.contributor.nonIdAuthorKoom, Woong Sub-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorgastric cancer-
dc.subject.keywordAuthorrecurrence-
dc.subject.keywordAuthorgastrectomy-
dc.subject.keywordAuthorsurvival-
dc.subject.keywordAuthorrecursive partition analysis-
dc.subject.keywordPlusRANDOMIZED CONTROLLED-TRIAL-
dc.subject.keywordPlusINTRAPERITONEAL CHEMOTHERAPY-
dc.subject.keywordPlusADJUVANT CHEMOTHERAPY-
dc.subject.keywordPlusCURATIVE SURGERY-
dc.subject.keywordPlusCOMPETING RISK-
dc.subject.keywordPlusPHASE-II-
dc.subject.keywordPlusS-1-
dc.subject.keywordPlusCHEMORADIOTHERAPY-
dc.subject.keywordPlusCARCINOMATOSIS-
dc.subject.keywordPlusCELLS-
Appears in Collection
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 13 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0